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Purpose: Activation of the innate immune system and
chronic low-grade inflammation are thought to be involved in
the pathogenesis of atherosclerosis and also thought to be
associated with type 2 diabetes and its complications. As a
receptor for bacterial lipopolysaccharide and heat-shock
proteins, Toll-like receptor 4 (TLR4) is one of the central
regulators of the immune response. Recent studies have
reported an association between TLR4 polymorphisms and
diabetes and its complications in Caucasian populations.
Materials and Methods: In this study, we analyzed the
association between TLR4 gene polymorphisms in patients
with features of type 2 diabetes and healthy controls in Korea.
Two polymorphisms of the TLR4 gene (Asp299Gly and
Thr399Ile) were examined in 225 diabetic patients and 153
healthy controls using polymerase chain reaction-restriction
fragment length polymorphism (PCR-RFLP) and single-strand
conformation polymorphism (SSCP). Results: No Asp299Gly
or Thr399Ile mutations were detected in any of the 378
subjects. Seven subjects from each group who had slightly
different SSCP patterns were selected for sequencing, but we
found no TLR4 polymorphisms on Exon3. The Asp299Gly and
Thr399Ile TLR4 gene polymorphisms were absent in both
groups, which was similar to the results for Japanese and
Chinese Han subjects. Conclusion: Our data and other Asian
data suggest that a racial difference can be found in the
frequency of the TLR4 polymorphism.
Key Words: Type 2 diabetes, TLR4, polymorphism, inflamma-
tion, innate immunity
INTRODUCTION
A homologous family of toll receptors, the
toll-like receptors (TLRs), was discovered in 1997.
1
TLRs serve as pattern-recognition receptors in
mammals and play a critical role in the
recognition of microbial components, such as
lipopolysaccharides (LPSs), which initiate the
innate immune response.
1 TLR4, a member of the
TLR family, is expressed on cardiomyocytes,
macrophages, airway epithelium, and endothelial
and smooth muscle cells.
2,3 TLR4 interacts with
endogenous ligands, including oxidized low-
density lipoprotein, heat-shock proteins 60 and 70,
fibrinogen, and fibronectin, which are elevated in
diabetic patients,
4-8 as well as with exogenous
ligands, such as LPS.
2,9-12 Twenty-nine single
nucleotide polymorphisms (SNPs) have been
identified in the human TLR gene.
13 Of these, the
Asp299Gly and 399 Thr399Ile polymorphisms have
been shown to cause hyporesponsiveness to LPS
in human alveolar macrophages and airway
epithelial cells.
14 Individuals carrying the Asp299Gly
TLR4 allele have lower levels of proinflammatory
cytokines, acute-phase reactants, and soluble
adhesion molecules, such as interleukin 6 and
fibrinogen.
15 Countering the increased risk of
severe bacterial infection, they have a lower risk
of carotid atherosclerosis and smaller intima-
media thickness in the common carotid artery.
15
Many studies have suggested that activation of
the innate immune system is closely associated
with type 2 diabetes. The circulating inflam-
matory markers interleukin 6, acute-phase
reactants, and especially C-reactive protein, have
been shown to predict the development of type 2
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diabetes.
16-20
Studies have analyzed the association between
TLR4 polymorphisms and the features of type 2
diabetes. Although one study reported a poor
relationship,
21 a recent study of 776 Caucasians,
including 246 with type 1 diabetes and 530 with
type 2 diabetes, indicated that 68 of those with
type 2 diabetes were heterozygous for the
Asp299Gly polymorphism (carrier rate (CR)
12.8%, allelic frequency (AF) 6.4%), 67 of them
were heterozygous for the TLR4 Thr399Ile poly-
morphism (CR 12.6%, AF 6.3%), and the type 2
diabetic subjects showed a strong association
between the Asp299Gly/TLR4 Thr399Ile polymor-
phism and diabetic neuropathy.
22 Since only one
other previous study has examined the TLR4
polymorphism in ethnic Korean subjects,
23 we
analyzed the association between the TLR4
polymorphism and features of type 2 diabetes in
Koreans.
MATERIALS AND METHODS
The study groups consisted of 378 Korean
subjects: 225 had type 2 diabetes (mean age, 54.5
± 10.0 years; 114 women and 111 men) and 153
were controls (mean age 46.1 ± 12.9 years; 77
women and 76 men). The diabetic patients were
recruited from the outpatient clinic of the
Department of Endocrinology, Gachon University
of Medicine and Science, Gil Medical Center,
Incheon, Korea. To be representative of the con-
trols in Korea, we selected people who were
recruited from the health care center during the
same study period and whose age was between
20 - 70 years old to cover all age groups. Physical
examinations and laboratory testing was per-
formed on all patients (Table 1).
PCR
DNA from both patients and controls was
extracted from peripheral white blood cells using
the standard method. The PCR primers for
Asp299Gly and TLR4 Thr399Ile had the following
sequences:
TLR4 Asp299Gly: forward 5'GATTAGCATAC
TTAGACTACTACCTCCATG3'
reverse 5'GATCAACTTCTGAAAAAGCATTC
CCAC3',
TLR4 Thr399Ile: forward 5'GGTTGCTGTTCTCA
Table 1. Basal Characteristics of Patients with type 2 Diabetes and Normal Controls
Variables Type 2 diabetes Normal controls
No. of patients 225 153
Sex (F/M) 80 : 73 140 : 85
Age (yrs) 55.9 ± 10.8 42.3 ± 9.2
BMI* (kg/ ) 23.6 ± 3.8 22.9 ± 3.0
Duration of diabetes 8.3 ± 6.4 -
SBP (mmHg) 124.2 ± 15.6 113.3 ± 12.3
DBP (mmHg) 72.6 ± 10.5 78.0 ± 46.6
FBS
§ (mmol/L) 159.4 ± 53.8 83.2 ± 4.0
HbA1c (%) 8.3 ± 1.9 5.1 ± 0.3
Cholesterol (mmol/L) 186.9 ± 38.0 181.3 ± 30.0
Triglycerides (mmol/L) 164.8 ± 114.7 100.4 ± 71.3
HDL-Chol. (mmol/L) 47.9 ± 15.2 55.4 ± 13.2
Data are means ± SD or %.
*Body mass index.
Systolic blood pressure.
Diastolic blood pressure.
§Fasting blood glucose.
High density lipoprotein-cholesterol.Yeun Sun Kim, et al.
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AAGTGATTTTGGGAGAA3'
reverse 5'ACCTGAAGACTGGAGAGTGAGAG
TTAAATGCT3'.
In total, 50 ng DNA were amplified in a 20- L μ
volume containing 0.4 L primer, 1 μ L DNA ex μ -
tract, 0.4 L Taq polymerase (Takara Bio, Otsu, μ
Japan), 2 L 10 μ × PCR buffer, and 2 L dNTPs. μ
Amplification consisted of two initial cycles at 9
4℃ for 30 s, 52℃ for 1 min, and 72℃ for 1 min,
followed by 30 cycles at 94℃ for 30 s, 55℃ for 30
s, and 72℃ for 30 s, followed by 5 min at 72℃,
and ending at 10℃.
Restriction enzymes
To screen for the TLR4 Asp299Gly and Thr
399Ile polymorphisms, the sequence was cleaved
using NcoI and HinfI restriction endonucleases,
respectively. Eight microliters of PCR product
were treated with 0.5 L restriction endonuclease, μ
and a drop of mineral oil was added. The mixture
was incubated at 37℃ for 24 h, and then electro-
phoresed on 2.5% NuSieve GTG (GeneFrontier,
Tokyo, Japan) and Seakem LE agarose gels
(GeneFrontier) at 100 V for 30 min.
SSCP (Single Strand Conformation Polymorphism)
To locate the TLR4 Asp299Gly polymorphism,
the PCR product was subjected to an SSCP study.
A mixture of 8 L of SSCP solution and 2 μ L of μ
PCR product was heated at 94°C for 5 min and
then iced for 2 min. The product was run on a
10% acrylamide gel at 150 V for 1.5 h and stained
using a Silverstar Staining Kit (Bioneer, Daejeon,
Korea).
DNA sequencing
Samples with different SSCP patterns were
selected, and the PCR products were sequenced
with the TLR4 Asp299Gly forward primer using
a commercial service (Macrogen , Seoul, Korea).
RESULTS
PCR DNA from type 2 diabetic patients using
the TLR4 Asp299Gly and TLR4 Thr399Ile primers
was not cut by the NcoI or HinfI restriction
endonucleases. No TLR4 Asp299Gly or Thr399Ile
polymorphisms were detected in the type 2
diabetics.
We examined the SSCP band patterns from the
DNA of 225 type 2 diabetics and 153 controls.
Seven SSCP bands from the 225 diabetic patients
and 7 of the 153 controls differed slightly from the
others. Therefore, we sequenced these 14 DNA
samples but detected no Asp299Gly polymor-
phisms at the TLR4 Exon 3 (Fig. 1).
DISCUSSION
Many studies in Caucasians suggest that the
Asp299Gly polymorphism is associated with
innate immunity-related diseases, such as chronic
inflammatory disease and atherosclerosis.
15,24,25
Therefore, association with the TLR4 polymor-
phism has been analyzed in type 2 diabetics with
features of mild systemic inflammation. Rudosky
et al. reported that the Asp 299Gly and Thr399Ille
genotypes of the TLR4 gene are associated with a
reduced prevalence of diabetic neuropathy in type
Fig. 1. The sequencing results for the samples in diabetic patients (A) and normal controls (B). The sequencing results
in all lanes were homozygous for adenine at position 896. No GAT(Asp) GGT(Gly) substitution was observed.
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2 diabetes.
21 In contrast, the Asp299Gly poly-
morphism was reported to be very rare in several
studies of Asian ethic groups.
26-29 Therefore, we
examined the ethnic differences in the TLR4
polymorphism and its association with type 2
diabetes, but were unable to find Asp299Gly and
Thr399Ile polymorphisms in 378 Korean subjects
(225 type 2 diabetics, and 153 controls).
Hang et al. failed to detect any homozygous or
heterozygous variant genotypes of the Asp299Gly
and Thr399Ile polymorphisms in 491 Han Chinese
subjects, consisting of cotton and silk textile
workers who were exposed to endotoxins.
26 In
addition, no Asp299Gly polymorphisms were
detected in ethnic Chinese patients in a study that
analyzed the association of ischemic stroke with
the TLR4 gene polymorphism
27 (although one
TLR4 gene C119A was found). A study on
polymorphisms of the TLR4 and CD 14 genes in
ulcerative colitis patients revealed no TLR4
Asp299Gly mutation in any Chinese patients or
healthy controls but detected mutations in 10% of
the Caucasian Dutch subjects.
28 Of 411 Japanese
subjects, including 197 critically ill patients and
214 healthy controls, no TLR4 Asp299Gly or
Thr399Ile polymorphisms were detected.
29
Even among Caucasian subjects, some studies
have suggested that the TLR4 Asp299Gly poly-
morphism is not related to conditions such as
rheumatoid arthritis and systemic lupus erythe-
matosus
30 or even the incidence of myocardial
infarction (MI) and stroke in a large prospective
study of US men.
31 Yang et al. reported that the
TLR4 polymorphism was not related to the
severity of atopy in asthmatics
33 or that of coronary
artery stenosis in 695 patients with atherosclerotic
MI.
33 Moreover, the TLR4 Asp299Gly variant had
no influence on LPS responsiveness or the
susceptibility to pulmonary tuberculosis in a
study in Gambia.
34
In conclusion, Asp299Gly and Thr399Ile TLR4
gene polymorphisms were not found in diabetic
patients and healthy controls in a Korean
population, findings that are similar to those for
Japanese and Chinese Han subjects. Therefore, our
data and other Asian data suggest that a racial
difference can be found in the frequency of the
TLR4 polymorphism.
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